7 Analysts Assess Alkermes: What You Need To Know
Portfolio Pulse from Benzinga Insights
Seven analysts have recently evaluated Alkermes (NASDAQ:ALKS), showing a mix of bullish to bearish sentiments. The average 12-month price target for ALKS is now $37.14, up 5.36% from the previous $35.25, with a high estimate of $50.00 and a low of $25.00. Analyst actions include maintaining, raising, and announcing ratings with price targets ranging from $25.00 to $50.00. Alkermes's financial performance shows strong revenue growth of 23.89%, a high net margin of 29.88%, and effective debt management with a debt-to-equity ratio of 0.31.
May 02, 2024 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Alkermes has received mixed analyst ratings but shows a positive trend in the average price target to $37.14, indicating a bullish outlook. The company's strong financial performance, with significant revenue growth and high net margin, supports a positive short-term impact.
The increase in the average price target and positive financial indicators such as revenue growth and net margin suggest a bullish sentiment among analysts. The diverse analyst opinions reflect caution, but the overall positive financial health and upward revision in price targets support a likely increase in stock price in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100